Search

Kevin J Sonnemann

from Madison, WI
Age ~47
Get Report
Also known as:
Kevin John Sonnemann, John R Sonnemann, Kevin Sonneman
Phone and address:
225 Merry St, Madison, WI 53704
(608) 770-3058
Related to:
Alex Guzman FortunaEric A Koster, 72Mary A Koster, 73Kristin Heather Sonnemann-Grams, 57Emily M Sonnemann, 45Cara S Sonnemann, 53David A Grams, 58John R Sonnemann, 80Elizabeth A Koster, 43Bonnie A Sonnemann, 82Katie M Sonnemann, 39Kristin H Sonnemann, 57Kyle R Sonnemann
Connected to:
Frank J Sonneman, 79Roy B Sonnema, 70Thomas E Sonnemann, 78William R Sonnemann, 62Alan F Sonnenberg, 72Amanda M Sonnenberg, 42Angie E Sonnenberg, 45Colleen D Sonnenberg, 47David P Sonnenburg, 40Eric C Sonnenberg, 45

Kevin Sonnemann Phones & Addresses

  • 225 Merry St, Madison, WI 53704 (608) 770-3058
  • 29 Hancock St, Madison, WI 53703
  • 1047 Gorham St, Madison, WI 53703
  • Kenosha, WI
  • Minneapolis, MN
  • Holland, MI
  • Traverse City, MI

Publications

Us Patents

Tat-Utrophin As A Protein Therapy For Dystrophinopathies

US Patent:
8409826, Apr 2, 2013
Filed:
Nov 5, 2010
Appl. No.:
12/940166
Inventors:
James M. Ervasti - Shoreview MN, US
Kevin J. Sonnemann - Minneapolis MN, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C07K 19/00
C12N 15/62
US Classification:
435 697, 514 165, 530350, 536 234
Abstract:
Disclosed is a fusion protein including a full-length TAT-utrophin or an anti-dystrophinopathic fragment thereof, a method of treating dystrophinopathies (including Duchenne muscular dystrophy) using the fusion protein, a pharmaceutical composition for treating dystrophinopathies in mammals comprising the fusion protein, and nucleic acid constructs for expressing the fusion protein.

Tat-Utrophin As A Protein Therapy For Dystrophinopathies

US Patent:
20090054327, Feb 26, 2009
Filed:
Nov 30, 2007
Appl. No.:
11/998798
Inventors:
James M. Ervasti - Shoreview MN, US
Kevin J. Sonnemann - Minneapolis MN, US
International Classification:
A61K 38/00
C07K 14/00
A61P 25/00
C12N 15/00
US Classification:
514 12, 530350, 4353201
Abstract:
Disclosed is a fusion protein including a full-length TAT-utrophin or an anti-dystrophinopathic fragment thereof, a method of treating dystrophinopathies (including Duchenne muscular dystrophy) using the fusion protein, a pharmaceutical composition for treating treating dystrophinopathies in mammals comprising the fusion protein, and nucleic acid constructs for expressing the fusion protein.
Control profile
Kevin J Sonnemann from Madison, WI, age ~47 Get Report